Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06671041 · ClinicalTrials.gov registry record · Phase 4
Treating Lid Wiper Epitheliopathy
A Phase 4 study, sponsored by Southern College of Optometry.
- Completed
- Registry status
- Phase 4
- Development phase
- 52
- Enrollment target
NCT06671041 is a Phase 4 study that has completed, run by Southern College of Optometry. The registered enrollment target is 52 participants.
The verdict
NCT06671041, a Phase 4 study, has completed, sponsored by Southern College of Optometry.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 52 participants
- Enrollment target
Study Summary
Lid wiper epitheliopathy (LWE) is a relatively new entry into the abundance of clinical ocular surface health signs. LWE was first reported in 2002 as a potential cause for dry eye disease (DED) (Korb et al., 2002). This clinical sign is visualised by everting the eyelid after a dye has been applied and observing the palpebral conjunctiva proximal to the eyelashes
Interventions
- DRUG Preservative Free eye drop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-05-27 |
| Est. Completion | 2024-08-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06671041
The ClinicalTrials.gov registry entry for NCT06671041 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern College of Optometry, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preservative Free eye drop is the first listed.
NCT06671041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06671041 about?
NCT06671041 is a clinical study titled "Treating Lid Wiper Epitheliopathy". Lid wiper epitheliopathy (LWE) is a relatively new entry into the abundance of clinical ocular surface health signs. LWE was first reported in 2002 as a potential cause for dry eye disease (DED) (Korb et al., 2002). This clinical sign is visualised by everting the eyelid after a dye has been applied...
What is the current status of trial NCT06671041?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 52 participants. The study started on 2024-05-27. Estimated completion is 2024-08-30.
What interventions are being tested in trial NCT06671041?
The interventions under investigation include: Preservative Free eye drop (DRUG).
Who is sponsoring clinical trial NCT06671041?
This trial is sponsored by Southern College of Optometry, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.